Mangalam Drugs and Organics posted its standalone results for Q3, showing a decline in total income by 4.4% to Rs. 80.35 crore, a slide from the same quarter the previous year. Net profits however increased Rs 3.79 crore in last year's December quarter to Rs. 6.2 crore this Q3, led by loweer operating and inventory costs.